--- title: "ADAMA Provides Financial Performance Estimation for the First Half of 2026" type: "News" locale: "en" url: "https://longbridge.com/en/news/292638409.md" description: "ADAMA Ltd. estimates its first-half 2026 adjusted net profit at $53-73 million, up from $49 million in H1 2025, driven by lower financial expenses despite reduced operating profit. Sales are expected to remain stable year-over-year, while adjusted EBITDA and margins are projected to decline due to higher operating expenses. Reported net profit is estimated at $52-72 million compared to a loss of $11 million previously. These preliminary figures exclude non-cash items and will be finalized in the August 18 financial statements." datetime: "2026-07-14T13:50:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/292638409.md) - [en](https://longbridge.com/en/news/292638409.md) - [zh-HK](https://longbridge.com/zh-HK/news/292638409.md) generator: "portal-rs" --- # ADAMA Provides Financial Performance Estimation for the First Half of 2026 TEL AVIV, Israel and BEIJING, July 14, 2026 /PRNewswire/ -- ADAMA Ltd. (the "Company") (SZSE 000553), today provided an estimate regarding its financial performance for the first half of 2026. **Sales** For the first half year of 2026, ADAMA is expecting to report stable sales in comparison to the first half year of 2025 (sales declined in RMB terms). This reflects higher volumes and the positive impact of exchange rates, offset by lower prices. Excluding the Company's decision to reduce the manufacture and sale of certain basic chemicals and low-margin products, sales would have increased. **Adjusted EBITDA and Net** **Profit** For the first half year of 2026, the Company is expecting to report a decrease in adjusted EBITDA and in its margin, in comparison to the first half year of 2025. This decline is despite an increase in gross profit and its margin and due to an increase in operating expenses. The Company expects to report an adjusted net profit in the range of $53 million to $73 million for the first half year of 2026, compared to a net profit of $49 million for the first half year of 2025. The expectation for higher net profit is despite lower adjusted operating profit and due to lower financial expenses. **Adjusted net profit** **Estimated** **First Half Year 2026** **First Half Year** **2025** Net profit attributable to shareholders (USD millions) 53-73 49 Earnings per share (USD) 0.0228-0.0314 0.0212 Net profit attributable to shareholders (RMB millions) 370-507 354 Earnings per share (RMB) 0.1587-0.2176 0.1521 Adjusted Net profit excludes the impact of transitory, non-operational or non-cash items, mainly including: i. Amortization of Transfer assets received and written-up due to 2017 ChemChina-Syngenta transaction (non-cash) ii. Amortization of acquisition-related PPA (non-cash) and other acquisition-related costs iii. Capital gain from sale of a subsidiary's logistics center in Israel iv. Restructuring costs (mainly in 2025) v. Fixed asset impairments related to improvement of operational efficiency vi. Repurchase of bonds by a controlled subsidiary in Q2 2025 **Reported Net Profit** The Company expects to report net profit (which includes the impact of the above adjusted items) for the first half year of 2026, in comparison to the first half year of 2025. This expectation is mainly due to higher operating profit and a decrease in financial expenses. **Reported net profit (loss)** **Estimated** **First Half Year 2026** **First Half Year** **2025** Net profit (loss) attributable to shareholders (USD millions) 52-72 (11) Earnings per share (USD) 0.0223-0.0309 (0.0048) Net profit (loss) attributable to shareholders (RMB millions) 364-501 (80) Earnings per share (RMB) 0.1562-0.2151 (0.0345) The estimated results of the Company are a preliminary estimation of the Company and have not been audited or reviewed by certified accountants. However, the Company and the external auditor have preliminarily communicated regarding relevant matters of the performance estimation and have no material disagreement. These estimations may change as a result of the further processing and analysis of the financial data that the Company will perform for the preparation of its financial statements, which are expected to be released after trading hours on August 18th, 2026. Investors are reminded to exercise caution when making investment decisions. **About ADAMA** ADAMA Ltd. is a global leader in crop protection, providing practical solutions to farmers across the world to combat weeds, insects and disease. Our culture empowers ADAMA's people to actively listen to farmers and ideas from the field. ADAMA's diverse portfolio of existing active ingredients, coupled with its leading formulation capabilities and proprietary formulation technology platforms, uniquely position the company to develop high-quality, innovative and sustainable products, to address the many challenges farmers and customers face today. ADAMA serves customers in dozens of countries globally, with direct presence in all top 20 markets. For more information, visit us at www.ADAMA.com. **Contact** Rivka Neufeld Investor Relations & Finance Governance Manager mail: ir@adama.com Zhujun Wang China Investor Relations Email: irchina@adama.com SOURCE ADAMA Ltd. ### Related Stocks - [200553.CN](https://longbridge.com/en/quote/200553.CN.md) - [000553.CN](https://longbridge.com/en/quote/000553.CN.md) ## Related News & Research - [07:26 ETADAMA Introduces Its First Pyrasulfotole-Based Product with the Launch of Marathon® in Australia](https://longbridge.com/en/news/284205179.md) - [HAV Group schedules Q2 2026 results webcast presentation](https://longbridge.com/en/news/296448086.md) - [Sui: Basecamp launches agentic finance products - 07 Oct 2026 to 08 Oct 2026](https://longbridge.com/en/news/296658135.md) - [Spacexfy Announces Expanded Global Investment Research and Portfolio Strategy for the Second Half of 2026](https://longbridge.com/en/news/296224972.md) - [Tobii schedules Q2 2026 interim report webcast presentation](https://longbridge.com/en/news/296061914.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**